An object of the present invention is to provide a pharmaceutical agents
for preventing and/or treating the progressive lesion after the organic
damage without inhibiting organic function or regeneration function
thereof, by selectively suppressing the induction of cytotoxic effector
macrophages which are induced into the damaged organs in response to
chemokines and cytokines which are expressed depending on the type of
damaged organic tissues.
